Cookies on this site

Researchers at Oxford Population Health studying genetic variants that control levels of Lipoprotein(a), or Lp(a) discovered that lowering Lp(a) could reduce the risk of heart attack and large artery stroke in both East Asians and Europeans. The study is published in Circulation.

DNA double helix

Lp(a) is a type of lipoprotein particle that is produced in the liver and carried in the blood. It is similar to a low-density lipoprotein (LDL) particle (that carries LDL-cholesterol), but in addition has an apolipoprotein(a) on its surface. Blood levels of Lp(a) in individuals are largely genetically determined.

Previous studies reported that higher blood levels of Lp(a) were strongly associated with higher risks of heart attack and only weakly with stroke in Europeans. It has been unclear whether higher levels of Lp(a) affect heart attack and stroke in East Asians that have a different genetic architecture to Europeans.

In this study, researchers examined the genetic determinants of Lp(a) in blood samples from 18,174 East Asians in the China Kadoorie Biobank to discover genetic variants that affect Lp(a) levels and compared their results with Europeans. Analyses of genetic variants affecting Lp(a) in population studies of heart attack and stroke cases in both populations enabled scientists to predict whether both could benefit from having lower levels of Lp(a).

Key findings:

  • The 29 genetic variants identified that control blood levels of Lp(a) in East Asians differ from those in Europeans, but higher blood levels of Lp(a) had comparable relative risks of heart attack for equivalent differences in Lp(a) levels in East Asians and in Europeans;
  • The risks for equivalent differences in blood levels of Lp(a) were 3-fold greater for heart attack than for ischemic stroke and were largely limited to stroke types due to a blockage in blood supply to the brain and unrelated to stroke due a bleed in the brain.

 

Read the full story on the Nuffield Department of Population Health website.

 

Similar stories

Research shows for the first time that standard non-contrast CT scans can be analysed by AI to reveal hidden coronary inflammation

Researchers from 27 institutions across UK, USA, Europe and Australia, led by a team at the University of Oxford, have demonstrated how an AI technology can measure inflammation in the heart’s arteries using low-radiation CT heart scans typically used to measure calcium score.

Five European Research Council (ERC) Synergy Grants awarded to Oxford researchers for ambitious new collaborations

Five Oxford University academics are to co-lead ambitious new research projects backed by European Research Council (ERC) Synergy Grants, part of the EU’s Horizon Europe research and innovation programme. Synergy Grants support groups of two to four outstanding researchers who combine complementary expertise and resources to tackle ambitious scientific challenges that could not be addressed by individual teams alone.

Professor Ole Jensen (Department of Experimental Psychology) and colleagues received €13.6 million to discover when the brain is ready for language and social understanding

The team will use new wearable brain sensors to track cognitive development from before birth to eight years of age.

New 'molecular glue' helps break down antibiotic resistance enzymes in E. coli

Oxford University scientists have discovered a new approach to tackle antimicrobial resistance (AMR), using 'molecular glues' to encourage bacteria to destroy their own resistance-causing enzymes. The study has been published in Angewandte Chemie International Edition.

Stronger immune system may help protect against prostate cancer

Higher levels of proteins involved in activating and coordinating the immune system were associated with a lower risk of developing prostate cancer, in a new study led by researchers at the Nuffield Department of Population Health.

The Nuffield Department of Women's & Reproductive Health has published its Biennial Report 2024–26

The Biennial Report 2024–26 highlights two years of research excellence, innovation, collaboration and growth.